Chronic exposure to nicotine enhances insulin sensitivity through α7 nicotinic acetylcholine receptor-STAT3 pathway.

This study was to investigate the effect of nicotine on insulin sensitivity and explore the underlying mechanisms. Treatment of Sprague-Dawley rats with nicotine (3 mg/kg/day) for 6 weeks reduced 43% body weight gain and 65% blood insulin level, but had no effect on blood glucose level. Both insulin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tian-Ying Xu, Ling-Ling Guo, Pei Wang, Jie Song, Ying-Ying Le, Benoit Viollet, Chao-Yu Miao
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/62f2afa5fd794069b502659f445fc55e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:62f2afa5fd794069b502659f445fc55e
record_format dspace
spelling oai:doaj.org-article:62f2afa5fd794069b502659f445fc55e2021-11-18T08:05:24ZChronic exposure to nicotine enhances insulin sensitivity through α7 nicotinic acetylcholine receptor-STAT3 pathway.1932-620310.1371/journal.pone.0051217https://doaj.org/article/62f2afa5fd794069b502659f445fc55e2012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23251458/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203This study was to investigate the effect of nicotine on insulin sensitivity and explore the underlying mechanisms. Treatment of Sprague-Dawley rats with nicotine (3 mg/kg/day) for 6 weeks reduced 43% body weight gain and 65% blood insulin level, but had no effect on blood glucose level. Both insulin tolerance test and glucose tolerance test demonstrated that nicotine treatment enhanced insulin sensitivity. Pretreatment of rats with hexamethonium (20 mg/kg/day) to antagonize peripheral nicotinic receptors except for α7 nicotinic acetylcholine receptor (α7-nAChR) had no effect on the insulin sensitizing effect of nicotine. However, the insulin sensitizing effect but not the bodyweight reducing effect of nicotine was abrogated in α7-nAChR knockout mice. Further, chronic treatment with PNU-282987 (0.53 mg/kg/day), a selective α7-nAChR agonist, significantly enhanced insulin sensitivity without apparently modifying bodyweight not only in normal mice but also in AMP-activated kinase-α2 knockout mice, an animal model of insulin resistance with no sign of inflammation. Moreover, PNU-282987 treatment enhanced phosphorylation of signal transducer and activator of transcription 3 (STAT3) in skeletal muscle, adipose tissue and liver in normal mice. PNU-282987 treatment also increased glucose uptake by 25% in C2C12 myotubes and this effect was total abrogated by STAT3 inhibitor, S3I-201. All together, these findings demonstrated that nicotine enhanced insulin sensitivity in animals with or without insulin resistance, at least in part via stimulating α7-nAChR-STAT3 pathway independent of inflammation. Our results contribute not only to the understanding of the pharmacological effects of nicotine, but also to the identifying of new therapeutic targets against insulin resistance.Tian-Ying XuLing-Ling GuoPei WangJie SongYing-Ying LeBenoit ViolletChao-Yu MiaoPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 12, p e51217 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Tian-Ying Xu
Ling-Ling Guo
Pei Wang
Jie Song
Ying-Ying Le
Benoit Viollet
Chao-Yu Miao
Chronic exposure to nicotine enhances insulin sensitivity through α7 nicotinic acetylcholine receptor-STAT3 pathway.
description This study was to investigate the effect of nicotine on insulin sensitivity and explore the underlying mechanisms. Treatment of Sprague-Dawley rats with nicotine (3 mg/kg/day) for 6 weeks reduced 43% body weight gain and 65% blood insulin level, but had no effect on blood glucose level. Both insulin tolerance test and glucose tolerance test demonstrated that nicotine treatment enhanced insulin sensitivity. Pretreatment of rats with hexamethonium (20 mg/kg/day) to antagonize peripheral nicotinic receptors except for α7 nicotinic acetylcholine receptor (α7-nAChR) had no effect on the insulin sensitizing effect of nicotine. However, the insulin sensitizing effect but not the bodyweight reducing effect of nicotine was abrogated in α7-nAChR knockout mice. Further, chronic treatment with PNU-282987 (0.53 mg/kg/day), a selective α7-nAChR agonist, significantly enhanced insulin sensitivity without apparently modifying bodyweight not only in normal mice but also in AMP-activated kinase-α2 knockout mice, an animal model of insulin resistance with no sign of inflammation. Moreover, PNU-282987 treatment enhanced phosphorylation of signal transducer and activator of transcription 3 (STAT3) in skeletal muscle, adipose tissue and liver in normal mice. PNU-282987 treatment also increased glucose uptake by 25% in C2C12 myotubes and this effect was total abrogated by STAT3 inhibitor, S3I-201. All together, these findings demonstrated that nicotine enhanced insulin sensitivity in animals with or without insulin resistance, at least in part via stimulating α7-nAChR-STAT3 pathway independent of inflammation. Our results contribute not only to the understanding of the pharmacological effects of nicotine, but also to the identifying of new therapeutic targets against insulin resistance.
format article
author Tian-Ying Xu
Ling-Ling Guo
Pei Wang
Jie Song
Ying-Ying Le
Benoit Viollet
Chao-Yu Miao
author_facet Tian-Ying Xu
Ling-Ling Guo
Pei Wang
Jie Song
Ying-Ying Le
Benoit Viollet
Chao-Yu Miao
author_sort Tian-Ying Xu
title Chronic exposure to nicotine enhances insulin sensitivity through α7 nicotinic acetylcholine receptor-STAT3 pathway.
title_short Chronic exposure to nicotine enhances insulin sensitivity through α7 nicotinic acetylcholine receptor-STAT3 pathway.
title_full Chronic exposure to nicotine enhances insulin sensitivity through α7 nicotinic acetylcholine receptor-STAT3 pathway.
title_fullStr Chronic exposure to nicotine enhances insulin sensitivity through α7 nicotinic acetylcholine receptor-STAT3 pathway.
title_full_unstemmed Chronic exposure to nicotine enhances insulin sensitivity through α7 nicotinic acetylcholine receptor-STAT3 pathway.
title_sort chronic exposure to nicotine enhances insulin sensitivity through α7 nicotinic acetylcholine receptor-stat3 pathway.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/62f2afa5fd794069b502659f445fc55e
work_keys_str_mv AT tianyingxu chronicexposuretonicotineenhancesinsulinsensitivitythrougha7nicotinicacetylcholinereceptorstat3pathway
AT linglingguo chronicexposuretonicotineenhancesinsulinsensitivitythrougha7nicotinicacetylcholinereceptorstat3pathway
AT peiwang chronicexposuretonicotineenhancesinsulinsensitivitythrougha7nicotinicacetylcholinereceptorstat3pathway
AT jiesong chronicexposuretonicotineenhancesinsulinsensitivitythrougha7nicotinicacetylcholinereceptorstat3pathway
AT yingyingle chronicexposuretonicotineenhancesinsulinsensitivitythrougha7nicotinicacetylcholinereceptorstat3pathway
AT benoitviollet chronicexposuretonicotineenhancesinsulinsensitivitythrougha7nicotinicacetylcholinereceptorstat3pathway
AT chaoyumiao chronicexposuretonicotineenhancesinsulinsensitivitythrougha7nicotinicacetylcholinereceptorstat3pathway
_version_ 1718422231377248256